PROTEOSTASIS THERAPEUTICS, INC. Contracts & Agreements

147 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Pre-Funded Warrant dated March 7, 2025
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2025
Securities Exchange Agreement dated March 7, 2025
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2025
AGREEMENT AND PLAN OF MERGER among TUHURA BIOSCIENCES, INC., HURA MERGER SUB I, INC. HURA MERGER SUB II, LLC KINETA, INC. and CRAIG PHILIPS, solely in his capacity as STOCKHOLDERS...
Merger Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2024
CTF Agreement, dated December 11, 2024, by and between TuHURA and Kineta
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2024
Form of TuHURA Support Agreement
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2024
Form of Kineta Support Agreement
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2024
Form of Lock-Up Agreement
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2024
Settlement Agreement, dated as of September 13, 2024, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC
Settlement Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2024
Exclusivity and Right of First Offer Agreement, dated as of July 3, 2024, by and between Kineta, Inc. and TuHURA Biosciences, Inc
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2024
Settlement Agreement and Mutual Release, dated as of April 22, 2024, by and between Kineta, Inc. and RLB Holdings, Connecticut, LLC
Settlement Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CT
2024
Separation Agreement by and between Kineta, Inc. and Shawn Iadonato, Ph.D., dated March 1, 2024
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2024
Separation Agreement by and between Kineta, Inc. and Pauline Kenny, dated March 1, 2024
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2024
Fourth Amendment to Option and License Agreement (CD27), dated as of December 14, 2023, by and between Gigagen, Inc. and Kineta, Inc
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Amendment No. 6 to Securities Purchase Agreement, dated October 13, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2023
Form of Pre-Funded Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Common Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Wainwright Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Securities Purchase Agreement, dated as of October 3, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2023
Second Amendment to Option and License Agreement (CD27), dated as of December 21, 2022, by and between Gigagen, Inc. and the Company
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Amendment No. 5 to Securities Purchase Agreement, dated July 21, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2023
Form of Amendment No. 4 to Securities Purchase Agreement, dated May 1, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2023
Second Amendment to Option and License Agreement (VISTA), dated as of May 25, 2023, by and between Gigagen, Inc. and Kineta, Inc
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Third Amendment to Option and License Agreement (CD27), dated as of May 25, 2023, by and between Gigagen, Inc. and Kineta, Inc
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Pre-Funded Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Common Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Wainwright Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Securities Purchase Agreement, dated as of April 20, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2023
Open Market Sale AgreementSM, dated February 10, 2023, by and between Kineta, Inc. and Jefferies LLC
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2023
Kineta, Inc. 2022 Equity Incentive Plan and associated forms
Bonus & Incentive Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2022
Separation Agreement by and between the Company and Richard Peters, dated December 16, 2022
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Separation Agreement by and between the Company and Michael Wyzga, dated December 16, 2022
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Separation Agreement by and between the Company and Devin Smith, dated December 16, 2022
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Form of Amendment No. 1 to the Merger Agreement dated December 5, 2022
Merger Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Amendment No. 2 to the Securities Purchase Agreement dated December 5, 2022
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Warrant, dated December 5, 2022
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Amendment No. 2 to the Registration Rights Agreement, dated December 5, 2022
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Securities Purchase Agreement Amendment, dated October 24, 2022
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Warrant, dated October 24, 2022
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Registration Rights Agreement Amendment, dated October 24, 2022
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Kineta, Inc. Amended and Restated 2008 Stock Plan (the Kineta 2008 Plan) and associated forms
Stock Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2022
Kineta, Inc. 2010 Equity Incentive Plan (the Kineta 2010 Plan) and associated forms
Bonus & Incentive Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2022
First Amendment to Kineta 2010 Plan
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Second Amendment to Kineta 2010 Plan
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Kineta, Inc. 2020 Equity Incentive Plan (the Kineta 2020 Plan) and associated forms
Bonus & Incentive Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2022
Kineta Lease, dated as of November 19, 2010, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
First Amendment to Kineta Lease, dated as of August 12, 2011, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Second Amendment to Kineta Lease, dated as of August 28, 2012, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Third Amendment to Kineta Lease, dated as of February 28, 2013, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Fourth Amendment to Kineta Lease, dated as of June 28, 2016, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Fifth Amendment to Kineta Lease, dated as of June 30, 2020, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Asset Purchase Agreement, dated June 5, 2022, by and among Yumanity and Janssen
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Agreement and Plan of Merger, dated June 5, 2022, by and among Yumanity, Kineta and Merger Sub
Merger Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2022
Form of Yumanity Support Agreement, dated June 5, 2022, by and among Kineta, Yumanity and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Kineta Support Agreement, dated June 5, 2022, by and among Yumanity, Kineta and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Lock-up Agreement, dated June 5, 2022, by each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Form of Securities Purchase Agreement, dated June 5, 2022, by each of the parties named therein
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Registration Rights Agreement, dated June 5, 2022, by each of the parties named therein
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Lease Termination Agreement by and between Yumanity Therapeutics, Inc. and Ice Box, LLC dated as of May 16, 2022
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Separation Agreement by and between Yumanity Therapeutics, Inc. and Ajay Verma, dated as of February 9, 2022
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Separation Agreement by and between Yumanity Therapeutics, Inc. and Paulash Mohsen dated as of March 14, 2022
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
License Agreement by and between Yumanity Therapeutics, Inc. and MIL 40, LLC dated as of February 28, 2022
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2022
Termination Agreement by and between Yumanity Therapeutics, Inc. and MIL 40, LLC dated as of February 28, 2022
Termination Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2022
Employment Offer Letter by and between Yumanity Therapeutics, Inc. and Michael D. Wyzga, dated July 12, 2021 (redacted)
Employment Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2021
Sixth Amendment and Consent to Loan and Security Agreement dated as of April 13, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2021
A. Verma Offer Letter (redacted)
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2021
D. Smith Offer Letter (redacted)
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2021
Fifth Amendment and Consent to Loan and Security Agreement dated as of March 29, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2021
Open Market Sale Agreement SM, dated April 8, 2021, by and between Yumanity Therapeutics, Inc., and Jefferies LLC
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2021
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2021
Amended and Restated Warrant Agreement to Purchase Common Stock of the Company issued to Hercules Capital, Inc., dated December 22, 2020
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2021
Contingent Value Rights Agreement, dated as of December 22, 2020 by and among the Company and Shareholder Representative Services LLC
Services Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Unconditional Secured Guaranty and Pledge Agreement, dated December 22, 2020 by and between the Company (formerly known as Proteostasis Therapeutics, Inc.) and Hercules Capital,...
Guaranty Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
Fourth Amendment and Consent to Loan and Security Agreement dated as of December 22, 2020, by and among Yumanity, Inc. (formerly Yumanity Therapeutics, Inc.), the lenders party...
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
Registration Rights Agreement, dated as of December 22, 2020 by among the Company (formerly known as Proteostasis Therapeutics, Inc.) and certain purchasers listed therein
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Form of Director and Officer Indemnification Agreements
Indemnification Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan and forms of award agreements thereunder
Stock Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Subscription Agreement, dated as of December 14, 2020 by and among Proteostasis Therapeutics, Inc. and the Purchasers named therein
Subscription Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Form of Registration Rights Agreement
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
First Amendment to Merger Agreement, dated November 6, 2020, by and among PTI, Yumanity, Holdings and Merger Sub
Merger Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of Support Agreement, by and between Proteostasis Therapeutics, Inc., Yumanity Therapeutics, Inc. and Yumanity Holdings, LLC
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Tangible Property and Exclusive Patent License Agreement, by and between Yumanity Therapeutics, Inc., Yumanity Holdings, LLC and Whitehead Institute for Biomedical Research, dated...
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
License Agreement, by and between Yumanity Therapeutics, Inc. and MIL 40G LLC, dated as of February 5, 2020
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Loan and Security Agreement, by and among Yumanity Therapeutics, Inc. and Hercules Capital, Inc., dated as December 20, 2019
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
Warrant Agreement to Purchase Preferred Units of Yumanity Holdings, LLC issued to Hercules Capital, Inc., dated December 20, 2019
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
U.S. Small Business Administration Paycheck Protection Program Note with Silicon Valley Bank, dated as of April 24, 2020
Note Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Common Unit Warrant issued to Alexandria Equities, LLC (as predecessor to Alexandria Venture Investments, LLC) on October 9, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Common Unit Warrant issued to Redmile Capital Offshore II Master Fund, Ltd. on August 14, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Common Unit Warrant issued to Redmile Biotechnologies Investments I AF, LP (as predecessor to Redmile Biopharma Investments I, L.P.) on August 14, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Common Unit Warrant issued to N. Anthony Coles on August 14, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Warrant to Purchase Limited Liability Company Interests issued to Silicon Valley Bank on June 14, 2018
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Warrant to Purchase Limited Liability Company Interests issued to Oxford Finance LLC dated June 14, 2018
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Agreement and Plan of Merger and Reorganization, dated August 22, 2020, by and among PTI, Yumanity, Holdings and Merger Sub
Merger Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of CVR Agreement by and between PTI and the CVR Rep
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of PTI Support Agreement, dated August 22, 2020, by and between Yumanity, PTI and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of Yumanity Support Agreement, dated August 22, 2020, by and between PTI, Yumanity and each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Form of PTI Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Form of Yumanity Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Amended and Restated Employment Agreement between the Registrant and Ben Munoz, dated March 9, 2020
Employment Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Amended and Restated Employment Agreement between the Registrant and Marija Zecevic, dated March 9, 2020
Employment Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Form of Amended and Restated Executive Agreement
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Form of Executive Employment Agreement
Employment Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Separation Agreement and General Release between the Company and Po-Shun Lee, dated as of July 22, 2019
Separation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2019
Consulting Agreement between the Company and Po-Shun Lee, dated as of July 23, 2019
Consulting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2019
Sales Agreement dated May 9, 2019 by and between Proteostasis Therapeutics, Inc. and H.C. Wainwright & Co., LLC
Sales Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2019
Employment Agreement between the Company and Marija Zecevic, dated as of March 8, 2017
Employment Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2019
Employment Agreement between the Company and Sheila Wilson, dated as of May 18, 2017
Employment Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2019
Technology Transfer and License Agreement between the Company and Genentech, Inc., dated December 13, 2018
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2019
Assignment and Release Agreement between the Company and Cystic Fibrosis Foundation, dated December 19, 2018
Release Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2019
Underwriting Agreement, dated October 23, 2018
Underwriting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2018
Fourth Amendment to Lease dated April 13, 2018 by and between ARE-Tech Square, LLC and the Company
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2018
First Amendment to Lease dated April 13, 2018 by and between Ice Box, LLC and the Company
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2018
Amendment No. 6 to Collaboration and License Agreement dated April 23, 2018 by and between the Company and Astellas Pharma Inc
Collaboration Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2018
Consulting Agreement dated May 7, 2018 by and between the Company and Danforth Advisors, LLC
Consulting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2018
Offer Letter, dated August 3, 2018, by and between the Company and Sandra Zimmerman
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2018
Sales Agreement dated March 23, 2018 by and between Proteostasis Therapeutics, Inc. and Leerink Partners LLC
Sales Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2018
Non-Employee Director Compensation Policy
Compensation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2018
Employment Agreement between the Company and Benito Munoz, dated as of October 17, 2016
Employment Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2018
Underwriting Agreement, dated December 13, 2017
Underwriting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2017
ProteostasisTherapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2017
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. [] Shares Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2016
Amendment No. 5 to Collaboration and License Agreement
Collaboration Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Amendment No. 4 to Collaboration and License Agreement
Collaboration Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2016
CONSULTING AGREEMENT
Consulting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | ###-###-####
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2016
Proteostasis Therapeutics, Inc. [] Shares Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2016
THIRD AMENDED ANDRESTATED STOCKHOLDERS AGREEMENT
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2016
PROTEOSTASIS THERAPEUTICS, INC. 2016 STOCKOPTION AND INCENTIVE PLAN
Bonus & Incentive Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2016
PROTEOSTASIS THERAPEUTICS, INC. SENIOREXECUTIVE CASH INCENTIVE BONUS PLAN
Bonus & Incentive Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2016
PROTEOSTASIS THERAPEUTICS, INC. 2016 EMPLOYEESTOCK PURCHASE PLAN
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2016
PROTEOSTASIS THERAPEUTICS, INC. NON-EMPLOYEEDIRECTOR COMPENSATION POLICY
Compensation Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2016
Void after 5:00p.m. New York Time on the Expiration Date (as defined below)
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2015
RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between Proteostasis Therapeutics, Inc. and Cystic FibrosisFoundation Therapeutics, Inc. Dated March 20, 2012
Development Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2015
AMENDED AND RESTATED LICENSE AGREEMENT
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2015
COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BY AND BETWEEN PROTEOSTASIS THERAPEUTICS, INC. and BIOGEN IDEC NEWVENTURES INC. December 5, 2013
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2015
COLLABORATION AND LICENSEAGREEMENT BETWEEN ASTELLAS PHARMA INC. AND PROTEOSTASIS THERAPEUTICS, INC.
Collaboration Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2015
PROTEOSTASIS THERAPEUTICS, INC. 2008 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2015
LEASE AGREEMENT
Lease Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2015
PROTEOSTASIS THERAPEUTICS, INC. FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2015
PROTEOSTASIS THERAPEUTICS, INC. CONSULTING AGREEMENT
Consulting Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2015
Amendment No. 2 to Collaboration and License Agreement
Collaboration Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2015
Amendment No. 3 to Collaboration and License Agreement
Collaboration Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2015